RecruitingNot Applicable

Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

United Kingdom100 participantsStarted 2024-11-27

Plain-language summary

To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All patients \>/= 18 years old and able to provide informed consent
✓. Patients with a diagnosis of chronic pulmonary aspergillosis
✓. To speak and understand English
✓. Able to provide informed consent

What they're measuring

Impact of Chronic Pulmonary Aspergillosis (CPA) on health status and Well-being.

Timeframe: 30 months

Trial details

NCT IDNCT06885905

SponsorImperial College London

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-23

Contact for this trial

Dareen Marghlani, MSc

dsm20@ic.ac.uk dsm20@ic.ac.uk

View on ClinicalTrials.gov More Chronic Pulmonary Aspergillosis trials